Finance

Lists
Why is 082800 up 2,18%?
Dive Deeper
082800:KOSDAQ
Vivozon Pharmaceutical Co Ltd
3 050,00 ₩
+2,18%
(+65,00) 1D
13 նոյ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 082800...
Open
3 000 ₩
High
3 070 ₩
Low
2 955 ₩
Mkt. cap
185,19 մլրդ
Avg. vol.
147,99 հզր
Volume
64,39 հզր
52-wk high
6 430 ₩
52-wk low
2 070 ₩
EPS
-620 ₩
Shares outstanding
60,72 մլն
No. of employees
176
Open
3 000 ₩
High
3 070 ₩
Low
2 955 ₩
Mkt. cap
185,19 մլրդ
Avg. vol.
147,99 հզր
Volume
64,39 հզր
52-wk high
6 430 ₩
52-wk low
2 070 ₩
EPS
-620 ₩
Shares outstanding
60,72 մլն
No. of employees
176
News stories
From web sources and news partners
About Vivozon Pharmaceutical Co Ltd
CEO-
Employees176
Founded2002
Headquarters-
SectorHealth Care
Industry-
Websitelumimicro.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
6,76 մլրդ
16,20 մլրդ
14,11 մլրդ
13,28 մլրդ
Cost of goods sold
7,80 մլրդ
9,56 մլրդ
8,29 մլրդ
6,56 մլրդ
Cost of revenue
7,80 մլրդ
9,56 մլրդ
8,29 մլրդ
6,56 մլրդ
Research and development expenses
534,26 մլն
755,11 մլն
728,70 մլն
810,89 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,21 մլրդ
8,82 մլրդ
7,45 մլրդ
7,21 մլրդ
Operating expense
9,17 մլրդ
10,37 մլրդ
8,84 մլրդ
8,66 մլրդ
Total operating expenses
16,96 մլրդ
19,93 մլրդ
17,13 մլրդ
15,22 մլրդ
Operating income
-10,20 մլրդ
-3,73 մլրդ
-3,02 մլրդ
-1,94 մլրդ
Other non operating income
-3,76 մլն
276,32 մլն
-847,04 մլն
-7,14 մլն
EBT including unusual items
-11,58 մլրդ
-12,73 մլրդ
-5,55 մլրդ
-2,89 մլրդ
EBT excluding unusual items
-11,58 մլրդ
-6,14 մլրդ
-5,55 մլրդ
-2,95 մլրդ
Income tax expense
-
48,61 մլն
-
-50,45 մլն
Effective tax rate
-
-0,38%
-
1,75%
Other operating expenses
-
-
-
-
Net income
-11,64 մլրդ
-12,79 մլրդ
-5,56 մլրդ
-2,84 մլրդ
Net profit margin
-172,29%
-78,93%
-39,40%
-21,38%
Earnings per share
-
-
-
-
Interest and investment income
18,83 մլն
99,82 մլն
40,18 մլն
67,22 մլն
Interest expense
-551,99 մլն
-629,92 մլն
-740,02 մլն
-430,30 մլն
Net interest expenses
-533,16 մլն
-530,10 մլն
-699,85 մլն
-363,08 մլն
Depreciation and amortization charges
202,63 մլն
196,55 մլն
191,40 մլն
171,79 մլն
EBITDA
-9,17 մլրդ
-2,44 մլրդ
-1,75 մլրդ
-698,53 մլն
Gain or loss from assets sale
-392,79 հզր
91,78 մլն
-1,65 մլն
-63,40 մլն
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps